AUTONOMIX MEDICAL, INC. Increase (Decrease) in Accounts Payable, Trade
AUTONOMIX MEDICAL, INC. (AMIX) reported Increase (Decrease) in Accounts Payable, Trade of -$329.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2026-08-13
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-06-30 was -$329.00K, a 335.00% decline year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2026-03-31 was $22.00K, a 88.04% decline year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-12-31 was -$164.00K.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for the quarter ending 2025-09-30 was $26.00K, a 90.91% decline year-over-year.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for fiscal 2026 was $24.00K, a 86.96% decline from fiscal 2025.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for fiscal 2025 was $184.00K, a 42.50% decline from fiscal 2024.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for fiscal 2024 was $320.00K, a 295.06% increase from fiscal 2023.
- AUTONOMIX MEDICAL, INC. increase (decrease) in accounts payable, trade for fiscal 2023 was $81.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$329.00K 10-Q · filed 2026-08-13 | -$307.00K derived: sum of 2 quarters · filed 2026-08-13 | -$471.00K derived: sum of 3 quarters · filed 2026-08-13 | -$445.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27 | -$142.00K derived: sum of 2 quarters · filed 2026-05-27 | -$116.00K derived: sum of 3 quarters · filed 2026-05-27 | $24.00K 10-K · filed 2026-05-27 |
| 2025-12-31 | -$164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$138.00K derived: sum of 2 quarters · filed 2026-02-11 | $2.00K 10-Q · filed 2026-02-11 | $186.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $166.00K 10-Q · filed 2025-11-12 | $350.00K derived: sum of 3 quarters · filed 2026-08-13 | $8.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $140.00K 10-Q · filed 2026-08-13 | $324.00K derived: sum of 2 quarters · filed 2026-08-13 | -$18.00K derived: sum of 3 quarters · filed 2026-08-13 | $268.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $184.00K 10-K · filed 2025-05-29 | -$158.00K derived: sum of 2 quarters · filed 2026-02-11 | $128.00K derived: sum of 3 quarters · filed 2026-02-11 | $184.00K 10-K · filed 2026-05-27 |
| 2024-12-31 | -$342.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$56.00K derived: sum of 2 quarters · filed 2026-02-11 | -$261.00K 10-Q · filed 2026-02-11 | $59.00K derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | $286.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12 | $81.00K 10-Q · filed 2025-11-12 | $401.00K derived: sum of 3 quarters · filed 2025-11-12 | $661.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$205.00K 10-Q · filed 2025-08-13 | $115.00K derived: sum of 2 quarters · filed 2025-08-13 | $375.00K derived: sum of 3 quarters · filed 2025-08-13 | $396.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $320.00K 10-K · filed 2025-05-29 | $580.00K derived: sum of 2 quarters · filed 2025-05-29 | $601.00K derived: sum of 3 quarters · filed 2025-05-29 | $320.00K 10-K · filed 2024-05-31 |
| 2023-12-31 | $260.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-13 | $281.00K derived: sum of 2 quarters · filed 2025-02-13 | $490.00K 10-Q · filed 2025-02-13 | |
| 2023-09-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-08 | $230.00K 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $209.00K 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | $81.00K 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |